New clinical trial find that immune drug ‘nivolumab’ improve immune system to fight against most common form of lung cancer. Nivolumab increases the survival rate among those patients who suffering from squamous…
Everything about lung cancer is here.
New clinical trial find that immune drug ‘nivolumab’ improve immune system to fight against most common form of lung cancer. Nivolumab increases the survival rate among those patients who suffering from squamous…